FDA Backs 23andMe Tests For Parkinson's, Alzheimer's Risks
The U.S. Food and Drug Administration on Thursday cleared a new generation of direct-to-consumer genetic tests from 23andMe Inc., expanding options in the field of personal genetics and easing future approvals...To view the full article, register now.
Already a subscriber? Click here to view full article